Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes

scientific article published on 8 June 2007

Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1136/THX.2006.074351
P932PMC publication ID2117137
P698PubMed publication ID17557769
P5875ResearchGate publication ID6278675

P50authorJohn R StradlingQ37830531
P2093author name stringDavid R Matthews
Tara M Wallace
Debby J Nicoll
Sophie D West
P2860cites workImpact of sleep debt on metabolic and endocrine functionQ23731787
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manQ26776977
Banting lecture 1988. Role of insulin resistance in human diseaseQ29547283
The occurrence of sleep-disordered breathing among middle-aged adultsQ29547889
Glucose clamp technique: a method for quantifying insulin secretion and resistanceQ34191986
Sleep-disordered breathing, glucose intolerance, and insulin resistanceQ35174358
An increase in insulin sensitivity and basal beta-cell function in diabetic subjects treated with pioglitazone in a placebo-controlled randomized study.Q42461955
Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazoneQ43584208
Obstructive sleep apnea is independently associated with insulin resistance.Q43903080
Sleep-disordered breathing and insulin resistance in middle-aged and overweight men.Q43903083
Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitusQ44211004
Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolismQ44286338
Acarbose improves glycemic control in overweight type 2 diabetic patients insufficiently treated with metforminQ44291151
Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome.Q44598192
Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apneaQ45287871
The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and type 2 diabetesQ47983895
Improvement of metabolic function in sleep apnea: the power of positive pressureQ48605611
Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trialQ48672164
Measurement properties of the calgary sleep apnea quality of life indexQ48673246
CPAP treatment does not affect glucose-insulin metabolism in sleep apneic patients.Q48696352
Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trialQ48759031
Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsivenessQ48829306
Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.Q51555713
Pioglitazone (AD-4833) ameliorates insulin resistance in patients with NIDDM. AD-4833 Glucose Clamp Study Group, Japan.Q51570683
U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study GroupQ56914456
The glucose clamp procedure activates the sympathetic nervous system even in the absence of hyperinsulinemiaQ71825659
A behavioural test to assess daytime sleepiness in obstructive sleep apnoeaQ73897062
Effect of nasal CPAP treatment on insulin sensitivity and plasma leptinQ73897067
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectpreproinsulinQ7240673
insulin resistanceQ1053470
type 2 diabetesQ3025883
P304page(s)969-974
P577publication date2007-06-08
P1433published inThoraxQ7796158
P1476titleEffect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes
P478volume62

Reverse relations

cites work (P2860)
Q91665299A Clinical Perspective of Sleep and Andrological Health: Assessment, Treatment Considerations, and Future Research
Q36369792A Randomized Controlled Trial of Continuous Positive Airway Pressure on Glucose Tolerance in Obese Patients with Obstructive Sleep Apnea.
Q26751303A clinical approach to obstructive sleep apnea as a risk factor for cardiovascular disease
Q35875603A controlled trial of CPAP therapy on metabolic control in individuals with impaired glucose tolerance and sleep apnea
Q47730287A randomized controlled trial: branched-chain amino acid levels and glucose metabolism in patients with obesity and sleep apnea
Q47692821Aiding sleep in type 2 diabetes: therapeutic considerations
Q35884314Among Metabolic Factors, Significance of Fasting and Postprandial Increases in Acyl and Desacyl Ghrelin and the Acyl/Desacyl Ratio in Obstructive Sleep Apnea before and after Treatment
Q47992681Association between obstructive sleep apnea severity and glucose control in patients with untreated versus treated diabetes
Q47683038Association between severity of obstructive sleep apnea and glycated hemoglobin level in Japanese individuals with and without diabetes
Q37504129Association of obstructive sleep apnea in rapid eye movement sleep with reduced glycemic control in type 2 diabetes: therapeutic implications
Q28390480Associations between Obstructive Sleep Apnea, Sleep Duration, and Abnormal Fasting Glucose. The Multi-Ethnic Study of Atherosclerosis
Q58694033Associations between Sleep-Disordered Breathing and Metabolic Risk Factors beyond Obesity
Q38759460Biological plausibility linking sleep apnoea and metabolic dysfunction
Q38798156CPAP therapy for patients with sleep apnea and type 2 diabetes mellitus improves control of blood pressure.
Q37016611CPAP therapy of obstructive sleep apnea in type 2 diabetics improves glycemic control during sleep.
Q61454635Cardiovascular outcomes of continuous positive airway pressure therapy for obstructive sleep apnea
Q34125046Catecholamines, Adiponectin, and Insulin Resistance as Measured by HOMA in Children with Obstructive Sleep Apnea
Q37389100Changes in regional adiposity and cardio-metabolic function following a weight loss program with sibutramine in obese men with obstructive sleep apnea.
Q34365605Childhood obesity and obstructive sleep apnea syndrome
Q48411115Clinical and societal consequences of obstructive sleep apnea and excessive daytime sleepiness
Q26778707Clinical manifestations of sleep apnea
Q38323435Comorbidity of diabetes and obstructive sleep apnea in hospitalized patients
Q38163028Comparative effectiveness research in obstructive sleep apnea: bridging gaps between efficacy studies and clinical practice
Q35819605Comparison of the effects of continuous positive airway pressure and mandibular advancement devices on sleepiness in patients with obstructive sleep apnoea: a network meta-analysis.
Q49837379Continuous Positive Airway Pressure Therapy in Gestational Diabetes With Obstructive Sleep Apnea: A Randomized Controlled Trial
Q58779137Continuous Positive Airway Pressure Therapy on Nonalcoholic Fatty Liver Disease in Patients With Obstructive Sleep Apnea
Q47826069Continuous Positive Airway Pressure for Improving Glycemic Control in Type 2 Diabetes: Where Do We Stand?
Q58710225Continuous positive airway pressure effect on visual acuity in patients with type 2 diabetes and obstructive sleep apnoea: a multicentre randomised controlled trial
Q48318593Continuous positive airway pressure therapy reduces oxidative stress markers and blood pressure in sleep apnea-hypopnea syndrome patients
Q34878003Continuous positive airway pressure to improve insulin resistance and glucose homeostasis in sleep apnea
Q35646020Continuous positive airway pressure treatment: effect on serum lipids in patients with obstructive sleep apnoea
Q47841623CrossTalk opposing view: Sleep apnoea causes metabolic syndrome
Q48348990Diabetes in obstructive sleep apnea
Q90282482Diabetes sleep treatment trial: Premise, design, and methodology
Q36761975Distinct severity stages of obstructive sleep apnoea are correlated with unique dyslipidaemia: large-scale observational study.
Q37667009Do sleep disorders and associated treatments impact glucose metabolism?
Q34742943Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? A retrospective case review
Q36523384Effect of Continuous Positive Airway Pressure Therapy on Glycemic Excursions and Insulin Sensitivity in Patients with Obstructive Sleep Apnea-hypopnea Syndrome and Type 2 Diabetes
Q35773005Effect of Continuous Positive Airway Pressure on Adiponectin in Patients with Obstructive Sleep Apnea: A Meta-Analysis
Q40890648Effect of Continuous Positive Airway Pressure on Glycemic Control in Patients with Obstructive Sleep Apnea and Type 2 Diabetes. A Randomized Clinical Trial
Q40966867Effect of One Week of 8-Hour Nightly Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea on Glycemic Control in Type 2 Diabetes: A Proof-of-Concept Study
Q35622660Effect of Short Term CPAP Therapy in Obstructive Sleep Apnea Patients with Metabolic Syndrome
Q38641910Effect of continuous positive airway pressure on glucose metabolism in adults with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.
Q38024735Effect of continuous positive airway pressure on hemoglobin A(1c) in patients with obstructive sleep apnea: a systematic review and meta-analysis
Q48110732Effect of continuous positive airway pressure on type 2 diabetes mellitus and glucose metabolism
Q38005377Effect of continuous positive airway pressure therapy on glucose control
Q38384502Effect of one week of CPAP treatment of obstructive sleep apnoea on 24-hour profiles of glucose, insulin and counter-regulatory hormones in type 2 diabetes.
Q27021857Effects of CPAP-respiration on markers of glucose metabolism in patients with obstructive sleep apnoea syndrome: a systematic review and meta-analysis
Q38754827Effects of a lifestyle intervention on REM sleep-related OSA severity in obese individuals with type 2 diabetes
Q37545870Effects of continuous positive airway pressure on energy balance regulation: a systematic review
Q34192476Effects of continuous positive airway pressure on glycemic control and insulin resistance in patients with obstructive sleep apnea: a meta-analysis
Q35216456Effects of continuous positive airway pressure therapy on glycaemic control, insulin sensitivity and body mass index in patients with obstructive sleep apnoea and type 2 diabetes: a systematic review and meta-analysis
Q48288725Effects of continuous positive airway pressure therapy withdrawal in patients with obstructive sleep apnea: a randomized controlled trial
Q38256147Effects of continuous positive airway pressure treatment on glycaemic control and insulin sensitivity in patients with obstructive sleep apnoea and type 2 diabetes: a meta-analysis
Q30409888Effects of poor and short sleep on glucose metabolism and obesity risk
Q36282419Effects of positive airway pressure treatment on clinical measures of hypertension and type 2 diabetes
Q35879674Eight Hours of Nightly Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea Improves Glucose Metabolism in Patients with Prediabetes. A Randomized Controlled Trial
Q34535079Endothelial dysfunction in the microcirculation of patients with obstructive sleep apnea
Q35681064Epidemiological aspects of obstructive sleep apnea.
Q39352471Exhaled breath analysis in obstructive sleep apnea
Q33691016Genetic analysis of candidate SNPs for metabolic syndrome in obstructive sleep apnea (OSA)
Q42100696Hypoadiponectinemia is related to sympathetic activation and severity of obstructive sleep apnea
Q47755342Impact of Bariatric Surgery on Heme Oxygenase-1, Inflammation, and Insulin Resistance in Morbid Obesity with Obstructive Sleep Apnea
Q37590178Impact of OSA on biological markers in morbid obesity and metabolic syndrome
Q89159614Impact of Obstructive Sleep Apnoea on Type 2 Diabetes and Vice Versa
Q31023532Impact of effective versus sham continuous positive airway pressure on liver injury in obstructive sleep apnoea: Data from randomized trials.
Q36964889Impact of obstructive sleep apnea on insulin resistance and glucose tolerance in women with polycystic ovary syndrome
Q33695887Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes
Q34432361Insulin resistance in moderate to severe obstructive sleep apnea in nondiabetics and its response to continuous positive airway pressure treatment
Q26783727Insulin resistance, glucose intolerance and diabetes mellitus in obstructive sleep apnoea
Q37215486Interactions between pregnancy, obstructive sleep apnea, and gestational diabetes mellitus
Q38195883Interactions between sleep, circadian function, and glucose metabolism: implications for risk and severity of diabetes
Q34840423Intermittent hypoxemia and OSA: implications for comorbidities
Q37301887Intermittent hypoxia exacerbates pancreatic β-cell dysfunction in a mouse model of diabetes mellitus
Q34627676Intermittent hypoxia-induced glucose intolerance is abolished by α-adrenergic blockade or adrenal medullectomy
Q37086848Is sleep apnea an independent risk factor for prevalent and incident diabetes in the Busselton Health Study?
Q35311633Lack of association between impaired glucose tolerance and appetite regulating hormones in patients with obstructive sleep apnea
Q61454625Mechanisms of cardiovascular disease in obstructive sleep apnoea
Q37809742Mechanisms of vascular damage in obstructive sleep apnea
Q35193853Meta-analyses of the Association of Sleep Apnea with Insulin Resistance, and the Effects of CPAP on HOMA-IR, Adiponectin, and Visceral Adipose Fat
Q28081240Meta-analysis of randomised controlled trials of oral mandibular advancement devices and continuous positive airway pressure for obstructive sleep apnoea-hypopnoea
Q34340704Meta-analysis: continuous positive airway pressure improves insulin resistance in patients with sleep apnea without diabetes
Q64113034Metabolic Consequences of Obstructive Sleep Apnea Especially Pertaining to Diabetes Mellitus and Insulin Sensitivity
Q27008397Metabolic and glycemic sequelae of sleep disturbances in children and adults
Q28386791Metabolic consequences of sleep and circadian disorders
Q37146506Molecular signatures of obstructive sleep apnea in adults: a review and perspective.
Q26823972New frontiers in obstructive sleep apnoea
Q48335088Nocturnal hyperglycaemia in type 2 diabetes with sleep apnoea syndrome
Q43233937Nocturnal intermittent hypoxia and the development of type 2 diabetes: the Circulatory Risk in Communities Study (CIRCS).
Q42818117Nocturnal reduction in circulating adiponectin concentrations related to hypoxic stress in severe obstructive sleep apnea-hypopnea syndrome
Q48303659Normal and elevated HbA1C levels correlate with severity of hypoxemia in patients with obstructive sleep apnea and decrease following CPAP treatment
Q38259507Novel therapeutics for type 2 diabetes: insulin resistance
Q39120083OSA and cardiometabolic risk: What's the bottom line?
Q37944926Obesity, obstructive sleep apnoea and metabolic syndrome
Q38773146Obstructive Sleep Apnea and Diabetes: A State of the Art Review
Q89002575Obstructive Sleep Apnoea and Type 2 Diabetes
Q89159620Obstructive Sleep Apnoea in Pregnancy - More Questions than Answers
Q36191723Obstructive sleep apnea and abnormal glucose metabolism
Q34313633Obstructive sleep apnea and diabetic neuropathy: a novel association in patients with type 2 diabetes
Q37294284Obstructive sleep apnea and metabolic syndrome in spanish population
Q37998117Obstructive sleep apnea and stroke
Q43061638Obstructive sleep apnea and the metabolic syndrome.
Q35179113Obstructive sleep apnea and type 2 diabetes
Q30463385Obstructive sleep apnea and type 2 diabetes: is there a link?
Q33565324Obstructive sleep apnea as a risk factor for type 2 diabetes
Q26778430Obstructive sleep apnea as a risk factor for type 2 diabetes mellitus
Q37588811Obstructive sleep apnea in Type 2 diabetes and impact of continuous positive airway pressure therapy on glycemic control
Q41544307Obstructive sleep apnea in adults with type 1 and type 2 diabetes: perspectives from a quality improvement initiative in a university-based diabetes center
Q36779835Obstructive sleep apnea syndrome: natural history, diagnosis, and emerging treatment options
Q37464853Obstructive sleep apnea, immuno-inflammation, and atherosclerosis
Q30473890Obstructive sleep apnea: Role in the risk and severity of diabetes
Q59006546Obstructive sleep apnoea
Q33567701Obstructive sleep apnoea and Type 2 diabetes mellitus: are they connected?
Q34909223Obstructive sleep apnoea and its cardiovascular consequences
Q47721289Obstructive sleep apnoea in diabetes: Does it matter?
Q89216818Obstructive sleep apnoea syndrome
Q38243022Obstructive sleep apnoea, insulin resistance and adipocytokines
Q37610506Obstructive sleep apnoea--an update.
Q37678816Obstructive sleep apnoea/hypopnoea syndrome in adults with Down syndrome.
Q37929129Obstructive sleep apnoea: relevance to non-sleep clinicians
Q48392123Oxidative stress and metabolic changes after continuous positive airway pressure treatment according to previous metabolic disorders in sleep apnea-hypopnea syndrome patients.
Q30440658Pathophysiology of sleep apnea
Q38257985Prediabetes and associated disorders
Q37234414Prevalence of type 2 diabetes in patients with obstructive sleep apnea in a multi-ethnic sample.
Q39363428Quantity and quality of nocturnal sleep affect morning glucose measurement in acutely burned children
Q28069593Reconsidering first-line treatment for obstructive sleep apnea: a systematic review of the literature
Q38036777Relationship between sleep disorders and the risk for developing type 2 diabetes mellitus
Q42434353Response to comment on Grimaldi et al. Association of obstructive sleep apnea in rapid eye movement sleep with reduced glycemic control in type 2 diabetes: therapeutic implications. Diabetes Care 2014;37:355-363.
Q28076751Role of sleep quality in the metabolic syndrome
Q38099038Screening for obstructive sleep apnoea in obesity and diabetes--potential for future approaches
Q35927083Selective effects of CPAP on sleep apnoea-associated manifestations
Q55091259Sex Differences in the Prevalence and Modulators of Sleep-Disordered Breathing in Outpatients with Type 2 Diabetes.
Q30391282Sleep Disorders and Cardio-Renal Disease: Implications for Minority Populations
Q21328678Sleep and Metabolism: An Overview
Q33717848Sleep and diabetes
Q35786178Sleep and metabolic function
Q48093959Sleep apnea and diabetes: good friends or something more?
Q38540035Sleep apnea syndrome in endocrine clinics
Q33863155Sleep-disordered breathing and obesity: pathophysiology, complications, and treatment
Q38256622Sleep-disordered breathing, type 2 diabetes and the metabolic syndrome
Q41732455The Effect of OSA Therapy on Glucose Metabolism: It's All about CPAP Adherence!
Q46077767The Effect of Treatment of Obstructive Sleep Apnea on Glycemic Control in Type 2 Diabetes
Q35238348The association of obesity with insulin resistance in male patients with obstructive sleep apnea syndrome in Korea
Q38178936The effect of continuous positive airway pressure on metabolic variables in patients with obstructive sleep apnoea
Q47671246The effectiveness of an obstructive sleep apnea screening and treatment program in patients with type 2 diabetes
Q46364653The impact of CPAP on cardiovascular biomarkers in minimally symptomatic patients with obstructive sleep apnea: a pilot feasibility randomized crossover trial
Q47982656The impact of obstructive sleep apnea on high-sensitivity C-reactive protein in subjects with or without metabolic syndrome
Q44125240The impact of sleep apnea treatment on carbohydrate metabolism in patients with acromegaly.
Q37407812The price of obstructive sleep apnea-hypopnea: hypertension and other ill effects
Q36664107Time-dependent changes in glucose and insulin regulation during intermittent hypoxia and continuous hypoxia
Q64240915Treatment of Adult Obstructive Sleep Apnea With Positive Airway Pressure: An American Academy of Sleep Medicine Systematic Review, Meta-Analysis, and GRADE Assessment
Q41025468Treatment of Diabetes Mellitus Using iPS Cells and Spice Polyphenols
Q31122576Trends in CPAP adherence over twenty years of data collection: a flattened curve
Q37809074Update on Sleep and Its Disorders
Q39016385VAMONOS (Veterans Affairs' Metabolism, Obstructed and Non-Obstructed Sleep) Study: Effects of CPAP Therapy on Glucose Metabolism in Patients with Obstructive Sleep Apnea
Q41024999Verifying the Relative Efficacy between Continuous Positive Airway Pressure Therapy and Its Alternatives for Obstructive Sleep Apnea: A Network Meta-analysis
Q38202679Year in review 2013: Acute lung injury, interstitial lung diseases, sleep and physiology.
Q52618755[Frequently occurring sleep disorders].

Search more.